Highlights
• 2Q18 strong revenue growth of 7%; 2Q18 orders up significantly
• 2Q18 GAAP EPS of $0.60; 2Q18 non-GAAP EPS of $0.58
• Reiterated 2018 non-GAAP EPS guidance of $2.45 to $2.55 despite higher interest expense and integration costs
• Completed acquisition of Nordion medical isotope business on July 30, 2018
View the full release on our Investors Relations page.
Join the Q2 2018 BWX Technologies, Inc. Earnings Conference Call Webcast
Tuesday, Aug. 7 at 9 a.m. EST.
